Bivin & Associates’s AMN Healthcare AMN Stock Holding History

Bivin & Associates’s Portfolio AMN Stock Details AMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-10	Closed	-$1K	–	320
2022 Q1	$1K	Buy	+10	New	+$1.04K	﹤0.01%	269

Other funds holding AMN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bivin & Associates's AMN Position: Q2 2022 in Review

Bivin & Associates sold out of AMN Healthcare (AMN) in Q2 2022, closing a stake of 10 shares — an estimated $1K sold.

Bivin & Associates first reported a position in AMN in Q1 2022 and held it in 1 quarter. The position peaked at $1K in Q1 2022. 435 funds tracked by Wall St. Rank hold AMN as of Q2 2022.

Bivin & Associates reported no remaining AMN Healthcare position as of Q2 2022 after selling out during the quarter.
Bivin & Associates sold 10 AMN Healthcare shares in Q2 2022, an estimated $1K.
Bivin & Associates first reported a position in AMN Healthcare in Q1 2022 and held it in 1 quarter.
Bivin & Associates's AMN Healthcare position peaked at $1K in Q1 2022.
435 funds tracked by Wall St. Rank held AMN Healthcare as of Q2 2022.

Based on Bivin & Associates's 13F filing for Q2 2022, filed 11 Aug 2022.